Xilio Therapeutics, Inc.
XLO
$0.6957
-$0.0041-0.59%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 62.18% | 162.13% | 23.68% | 2.49% | -0.58% |
Total Receivables | -- | -93.33% | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -29.23% | -59.14% | -14.02% | -56.46% | 0.56% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 58.59% | 34.71% | 25.16% | -1.82% | -0.53% |
|
|||||
Total Current Assets | 58.59% | 34.71% | 25.16% | -1.82% | -0.53% |
Net Property, Plant & Equipment | -17.00% | -17.19% | -19.12% | -17.56% | -17.75% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -3.60% | -38.00% | 11.51% | 1.49% | 5.08% |
Total Assets | 48.89% | 25.55% | 16.66% | -4.09% | -2.69% |
|
|||||
Total Accounts Payable | 224.13% | 204.96% | 145.14% | -34.59% | 33.76% |
Total Accrued Expenses | -42.27% | -51.47% | -4.92% | 4.14% | 36.37% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 12.56% | 10.55% | -73.06% | -80.92% | -86.32% |
Total Finance Division Other Current Liabilities | 59.44% | 85.28% | -- | -- | -- |
Total Other Current Liabilities | 59.44% | 85.28% | -- | -- | -- |
Total Current Liabilities | 37.83% | 50.84% | 70.84% | 124.60% | 137.16% |
|
|||||
Total Current Liabilities | 37.83% | 50.84% | 70.84% | 124.60% | 137.16% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -16.71% | -15.58% | -14.59% | -13.69% | -12.92% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 555.43% | 122.66% | -- | -- | -- |
Total Liabilities | 124.50% | 63.63% | 121.91% | 111.82% | 125.99% |
|
|||||
Common Stock & APIC | 7.66% | 10.65% | 10.77% | 8.68% | 8.81% |
Retained Earnings | -15.76% | -15.84% | -17.89% | -20.40% | -22.51% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -78.85% | -58.47% | -52.21% | -60.05% | -50.40% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -78.85% | -58.47% | -52.21% | -60.05% | -50.40% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -78.85% | -58.47% | -52.21% | -60.05% | -50.40% |
|